 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is our internal ID - starting with VT.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
- For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
Keywords: |
 |
Vaccine, Heat Shock, Glioblastoma Multiforme |
 |
 |
 |
 |
Phase: |
 |
Phase 2 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT1930
NCT00912951
|
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
70: Cares for self, unable to perform normal activity or to do active work |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed: Y
Recurrent: N
Prior Surgery is Sometimes Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Newly diagnosed Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
07/07/2009 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Surgery Chemotherapy Radiation Immunological, Biological or Targeted Therapy. |
 |
 |
 |
 |
Contact: |
 |
U. Of California At San Francisco Michael Prados, MD Professor Contact: Dr. Michael Prados 400 Parnassus Avenue, Rm A808 San Francisco, CA 94143- Phone:(415)353-2966 Fax: (415)353-2167 Click here to send an email Website: neurosurgery.medschool.ucsf.edu/index.html |
 |
 |
|
|